Volume 1, Issue 2 (11-2014)                   vacres 2014, 1(2): 12-15 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ramezani A, Mohraz M, Banifazl M, Foroughi M, Eslamifar A, Aghakhani A. Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients. vacres 2014; 1 (2) :12-15
URL: http://vacres.pasteur.ac.ir/article-1-40-en.html
Department of Clinical Research, Pasteur Institute of Iran, Tehran, Iran
Abstract:   (7004 Views)
Background: Due to their similar routes of transmission, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infection occurs considerably. HBV infection progresses more rapidly in HIV-infected patients. Therefore, HBV vaccination of all non-immune HIV infected patients is recommended. On the other hand, HIV-infected subjects have suboptimal responses to HBV vaccine. In this study, we aimed to determine the immune responses to standard HBV vaccination in HIV-infected patients. Methods: Fifty-six HIV infected patients who lacked evidence of either prior HBV infection or immunity were subjected to standard HBV vaccination, as 3 intramuscular injections of the standard dose (20 μg) of recombinant HBV vaccine at months 0, 1 and 6. Hepatitis B surface antibody (anti-HBs) titers were checked in all cases one month after the vaccination. A protective antibody response was defined as an anti-HBs titer of ≥10 IU/L. Results: HBV seroprotection was observed in 56.6% of HIV-infected patients. There was no significant difference between cases with and without seroprotection regarding age, sex, possible route of HIV acquisition, CD4 count, receiving antiretroviral therapy (and its duration) and HCV infection. Conclusion: Our study confirms previous reports that HIV-infected patients have a lower response rate to the standard HBV vaccination compared to general population. So other strategies are needed to improve the HBV vaccine response rate in HIV cases.
Full-Text [PDF 295 kb]   (2163 Downloads)    
Type of Study: Original article |
Received: 1970/01/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.